Examining the effects of COVID-19 on pharmacy dispensing of naloxone and syringes sales across Massachusetts and New Hampshire

Journal article

Examining the effects of COVID-19 on pharmacy dispensing of naloxone and syringes sales across Massachusetts and New Hampshire

Derek Bolivar, Daniel Hartung, Joseph Silcox, Jeffrey Bratberg, Jesse Boggis, Megan Rabin and Traci C. Green

Journal of the American Pharmacists Association

10/15/2022

DOI: https://doi.org/10.1016/j.japh.2022.10.012

PMID: 36369076

Abstract

Brief Reports

COVID-19

Harm Reduction

Naloxone

Opioid Crisis

Over the Counter (OTC) Syringes

Pharmacy

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Metrics

11 Record Views

See more details

Details

Title: Examining the effects of COVID-19 on pharmacy dispensing of naloxone and syringes sales across Massachusetts and New Hampshire
Creators: Derek Bolivar - Brandeis University
Daniel Hartung - Oregon State University
Joseph Silcox - Brandeis University
Jeffrey Bratberg - University of Rhode Island
Jesse Boggis - Dartmouth Institute for Health Policy and Clinical Practice
Megan Rabin - University of Pittsburgh School of Public Health, Pittsburgh, PA, USA
Traci C. Green - Brandeis University
Publication Details: Journal of the American Pharmacists Association
Publisher: Published by Elsevier Inc. on behalf of the American Pharmacists Association
Identifiers: 9924169674201921
Academic Unit: Institute for Behavioral Health; Heller School for Social Policy and Management
Language: English
Resource Type: Journal article